Old Web
English
Sign In
Acemap
>
Paper
>
High Rates of Residual Vaccine Titers at 1-Year Post CD19 Chimeric Antigen Receptor T Cell Therapy
High Rates of Residual Vaccine Titers at 1-Year Post CD19 Chimeric Antigen Receptor T Cell Therapy
2021
Nishi Shah
Ana Alarcon
Meighan Palazzo
Josel D. Ruiz
Connie W Batlevi
Parastoo B. Dahi
M. Lia Palomba
Michael Scordo
Sergio Giralt
Craig S. Sauter
Miguel Angel Perales
Gunjan L. Shah
Keywords:
Chimeric Antigen Receptor T-Cell Therapy
high rate
Medicine
Titer
Virology
CD19
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]